2000/477/EC: Commission Decision of 24 July 2000 for purchase by the Community of Bluetongue vaccine for emergency stock (notified under document number C(2000) 2209)
Data as of 2026-07-04 Β· Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. Β· Read the official text β
1. For emergency use the Community shall make arrangements for the purchase of 500000 doses of trivalent bluetongue vaccine containing serotypes 4, 9 and 16 and 500000 doses of monovalent Bluetongue vaccine (serotype 2). 2. The arrangements referred to in paragraph 1 shall include the storage of vaccines in such a manner that they can be dispatched without delay to the area designated for vaccination.
The maximum cost of the measures referred to in Article 1 shall be up to EUR 160000.
1. To meet the objectives of Articles 1 and 2 the Commission shall conclude contracts without delay with the laboratory of Ondertesport in South-Africa. 2. The Director General of the Directorate General for Health and Consumer Protection shall be authorised to sign the contracts on behalf of the European Commission.
Decision 2000/292/EC(3) of 6 April 2000 is repealed.
This Decision is addressed to all the Member States. Done at Brussels, 24 July 2000. For the Commission David Byrne Member of the Commission (1) OJ L 224, 18.8.1990, p. 19. (2) OJ L 160, 26.6.1999, p. 103. (3) OJ L 95, 15.4.2000, p. 39.
Source: EUR-Lex (Publications Office of the EU), Β© European Union, reuse permitted under Commission Decision 2011/833/EU.